Tg Therapeutics TGTX Cash Flow Statement (2010-2026)

NASDAQ TGTX
$53.28 +0.08 (+0.14%)
As of: Oct 22, 2026 · 9:41 AM EDT
Reported Financials

Tg Therapeutics Quarterly Cash Flow Statement

Periods 62 quarters
Latest Jun 2026

Tg Therapeutics reported cash from operations of $39.26M and free cash flow of $38.97M for the quarter ended Jun 2026, up 428.0% year over year. This cash flow statement covers 62 quarters of results from Dec 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2010 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-85.64M-93.34M-69.01M-40.51M-35.82M-78.47M-39.23M-47.61M113.93M-14.42M-10.71M6.88M3.88M23.33M5.06M28.19M390.90M23.04M19.78M7.78M
Depreciation and DepletionDep. & Depletion
0.08M0.08M0.08M0.08M0.08M0.07M0.07M0.03M0.07M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M
Amortization of Deferred ChargesAmort. Deferred Charges
0.30M0.39M0.46M0.46M0.46M0.46M0.46M0.64M0.64M0.66M0.64M0.64M0.41M0.31M0.30M0.30M0.30M0.30M0.30M0.23M
Depreciation & Amortization (CF)Dep. & Amort.
0.08M0.08M0.08M0.08M0.08M0.07M0.07M0.03M0.07M0.04M0.03M0.02M0.01M0.01M0.01M0.01M0.02M0.02M0.03M0.05M
Share-based CompensationStock Comp.
14.00M14.38M2.12M-0.98M7.00M36.53M7.12M13.58M9.97M12.27M10.30M10.45M12.66M15.73M15.97M17.40M18.13M19.19M14.56M13.09M
Deferred Taxes
-366.63M18.63M3.86M0.71M
Gains from Investment SecuritiesGains Investment
0.20M-0.37M-0.08M-0.50M-0.10M-0.18M0.42M-0.43M1.53M1.23M
Asset Writedowns and ImpairmentWritedown
Other non-cash itemsOther Non-Cash
0.23M2.26M0.20M0.06M-0.19M2.43M0.13M0.11M0.60M-1.23M-1.23M-1.36M4.60M-2.79M-1.10M-0.37M0.19M9.27M
Change in Working Capital
Change in ReceivablesChange Receivables
0.45M0.01M-0.49M-0.81M-0.09M8.62M8.86M21.84M11.77M13.89M18.63M32.12M13.46M60.94M41.40M33.87M40.24M86.42M9.52M
Change in InventoryChange Inventory
26.92M1.97M2.54M5.51M36.93M2.56M2.54M24.82M46.31M-3.60M-8.70M-0.56M13.28M66.82M
Change in Accured ExpensesChange Accured Exp.
8.82M3.90M-10.17M-11.19M-6.08M16.43M9.86M9.28M-21.51M2.56M40.22M8.96M11.67M-38.01M65.18M8.24M-19.55M2.01M34.02M65.35M
Change in TaxesChange Taxes
0.41M-2.68M-6.72M-6.13M
Change in Other Operating AssetsOther Assets Change
2.83M1.25M-6.76M-1.30M0.21M-0.34M2.62M6.69M1.05M-7.53M-1.49M-1.05M25.59M-16.73M4.63M5.26M30.63M1.91M-10.66M-13.57M
Change in Other Operating LiabilitiesOther Liabilities Change
-1.47M-12.90M0.50M1.16M-2.12M0.25M-0.01M0.07M6.82M-0.87M3.04M0.51M16.75M-1.18M-2.26M0.75M8.37M-4.96M-8.03M6.63M
Other Working Capital ChangesOther WC Changes
-4.30M-14.16M7.26M2.46M-2.33M0.58M-2.64M-6.62M5.77M6.66M4.53M1.56M-8.84M15.55M-6.89M-4.51M-22.26M-6.87M2.63M20.20M
Cash from OperationsCash from Ops.
-67.20M-86.91M-68.69M-49.12M-34.50M-23.87M-59.90M-42.01M83.70M-13.21M-8.21M5.54M-12.21M-25.64M-28.72M7.44M-23.15M19.66M-17.89M39.26M
Investing Activities
Capital ExpendituresCapex
0.08M0.08M0.01M0.00M0.00M0.02M0.02M0.03M0.04M0.08M0.07M0.05M0.29M
Change in Property, Plant and EquipmentChange in PP&E
-0.08M-0.08M-0.01M0.00M0.00M-0.02M-0.02M-0.03M-0.04M-0.08M-0.07M-0.05M-0.29M
Acquisitions
Net of Acquisitions & DivestmentsNet Acquisitions
Purchase of InvestmentsInvestments Purchased
11.80M12.23M56.89M14.92M31.47M-99.28M22.17M56.28M68.43M82.66M69.73M101.61M57.89M93.31M53.30M31.31M45.57M21.06M16.43M
Sale and Maturity of InvestmentsInvestments Sold
11.25M15.60M13.23M25.30M28.48M20.27M16.00M30.50M26.05M23.68M73.40M71.50M92.30M73.70M80.40M49.35M77.75M30.00M11.25M17.75M
Other Investing ActivitiesOther investing
Cash from Investing ActivitiesCash from Investing
-0.63M3.29M-43.67M10.38M-2.99M16.27M-6.17M30.50M-30.23M-44.76M-9.26M1.77M-9.33M15.79M-12.93M-3.99M46.36M-15.64M-9.86M1.03M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
25.00M244.82M747.66M
Long-Term Debt RepaymentsLT Debt Repayment
Non-Current Debt
25.00M244.82M747.66M
Short-Term Debt repaymentsST Debt Repayment
Current Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
25.00M244.82M747.66M
Change in Capital Stock
Common Stock IssuedStock Issued
0.05M2.22M0.13M0.14M0.28M0.05M0.36M47.05M0.42M0.00M0.01M0.14M0.20M0.57M0.02M0.43M1.06M0.76M0.09M
Shares Repurchased
2.15M6.61M6.12M6.88M78.24M99.99M
Net Shares Issued and RepurchasedNet Shares Issued
0.05M2.22M0.13M0.14M0.28M0.05M0.36M47.05M0.42M0.00M0.01M0.14M-1.95M-6.04M-6.10M-6.44M-78.24M1.06M-99.23M0.09M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
0.05M2.22M0.13M0.14M0.28M0.05M0.36M47.05M0.42M0.00M0.01M0.14M-1.95M-6.04M-6.10M-6.44M-78.24M1.06M-99.23M0.09M
Other financing activitiesOther financing
-0.02M-0.81M-0.13M-0.86M-0.03M-2.60M
Cash from Financing ActivitiesCash from Financing
-7.36M56.00M-0.85M0.14M0.28M0.05M25.24M47.05M0.42M0.00M0.01M0.14M134.45M-6.07M-6.10M-6.44M-78.24M1.06M390.83M0.09M
Additional items
Change in Cash
-75.19M-27.62M-113.21M-38.60M-37.21M-7.55M-40.83M35.54M53.90M-57.97M-17.45M7.44M112.92M-15.93M-47.75M-3.00M-55.03M5.08M363.07M40.38M
Ending Cash Balance
300.15M111.13M103.58M62.75M98.29M152.18M94.22M76.77M84.20M197.12M181.19M133.44M130.44M75.41M80.49M443.56M483.94M
Free Cash FlowFCF
-67.28M-86.99M-68.70M-49.12M-34.50M-23.87M-59.90M-42.01M83.70M-13.21M-8.21M5.54M-12.23M-25.66M-28.74M7.39M-23.23M19.59M-17.95M38.97M
Net Cash FlowNCF
-75.19M-27.62M-113.21M-38.60M-37.21M-7.55M-40.83M35.54M53.90M-57.97M-17.45M7.44M112.92M-15.93M-47.75M-3.00M-55.03M5.08M363.07M40.38M
Interest Paid
1.54M1.75M2.18M4.84M2.45M2.49M7.11M6.42M6.14M6.10M6.10M5.91M2.39M18.28M
Income Taxes PaidTaxes Paid
0.50M5.08M1.96M0.85M3.44M7.88M

Tg Therapeutics Cash Flow Statement API

Pull Tg Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TGTX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY